Alexandria Real Estate Equities | ARE - Zysk Brutto

Cena Akcji
41.06
Dzienna Zmiana
0.65 1.61%
Miesięcznie
-11.30%
Rocznie
-43.49%
Q2 Prognozy TE
46.39




Zysk Brutto Zmiana Data
Alexandria Real Estate Equities USD 15.73B 16.73B 2026-03
Alnylam Pharmaceuticals USD 161.14M 77.83M 2025-12
American Homes 4 Rent USD 144.25M 27.45M 2025-12
Amgen USD 3.92B 2.35B 2025-09
AvalonBay Communities USD 165.69M 218.28M 2025-12
Boston Properties USD 133.01M 161.78M 2026-03
Brandywine Realty USD -36.85M 10.85M 2025-12
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Camden Property USD 159.41M 45.05M 2025-12
COPT Defense Properties USD 40.26M 1.02M 2026-03
Cousins Properties USD -3.28M 4.74B 2025-12
Digital Realty USD 190.81M 104.37M 2026-03
Douglas Emmett USD -21.2M 6.13M 2025-09
EastGroup Properties USD 3.58B 3.51B 2026-03
Eli Lilly USD 7.23B 456M 2025-09
EPR Properties USD 67.31M 9.01M 2025-09
Equity Lifestyle Properties USD 1.76B 1.66B 2026-03
Equity Residential USD 395.39M 94.14M 2025-12
Essex Property USD 112.21M 26.46M 2026-03
Gilead Sciences USD 2.08B 1.56B 2025-12
Healthpeak Properties Inc USD 125.11M 59.88M 2025-12
Highwoods Properties USD 29.72M 16.02M 2025-12
Hudson Pacific Properties USD -281.12M 106.59M 2025-12
Illumina USD 220M 86M 2025-09
Kilroy Realty USD 17.11M 145.17M 2025-12
LTC Properties USD 103.87M 853.98M 2025-12
Medical Properties USD -66.58M 88.96M 2025-09
Mid-America Apartment Communities USD 57.74M 45.68M 2025-12
National Health Investors USD 32.48M 4.21M 2025-09
Omega Healthcare Investors USD 171.3M 20.05M 2025-12
ProLogis USD 1.09B 472.12M 2026-03
Quest Diagnostics USD 334M 4M 2026-03
Realty Income USD 323.44M 18.06M 2025-12
Rexford Industrial Realty USD 94.56M 162.3M 2026-03
SL Green Realty USD -77.4M 26.32M 2026-03
STAG Industrial USD 3.59B 3.5B 2026-03
Terreno Realty USD 103.38M 10.1M 2025-09
UDR USD 238.32M 194.81M 2025-12
Ventas USD 43.11M 28.76M 2026-03
Veris Residential USD -15.53M 14.87M 2026-03
Vornado Realty USD 12.7M 954K 2025-12
W. P. Carey USD 191.13M 37.88M 2026-03
Welltower USD 345.24M 1.62B 2026-03